Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/908
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChung, Cecilia Ashley-
dc.date.accessioned2023-11-29T08:20:30Z-
dc.date.available2023-11-29T08:20:30Z-
dc.date.issued2023-06-12-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/908-
dc.description.abstractThe CoronaVirus Disease 2019 (COVID-19) caused by SARS-CoV-2 continues to be a global pandemic with substantial socioeconomic damages. Exploration of bioactive compounds from herbal resources with potential anti SARS-CoV-2 effects are currently on the rise. In particular, naturally-derived flavonoids are reported for its capability to inhibit 3-chymotrypsin like-protease (3CL), a promising drug target that is essential for SARS-CoV-2 replication and formation. In this paper, the flavonoid compounds in Foeniculum vulgare semen (Fennel seed) ethanolic crude extract are identified using UPLC-ESI-MS/MS, followed by binding affinity prediction of the identified flavonoid compounds toward SARS-CoV-2 3CL procrystal structure through in silico approaches, before ultimately assessing the inhibition level of the extract towards recombinant SARS-CoV-2 3CLpro in vitro. The results indicated that F. vulgare seed extract contains the flavonol class of flavonoids, specifically quercetin, kaempferol, and its glycosylated moieties which are well documented by previous studies to exert SARS-CoV-2 3CLpro inhibitory effects. Molecular docking analysis revealed strong binding affinity values of <-7 kcal/mol for all identified flavonols, with glycosylated moieties displaying a more negative value than aglycone flavonols. Quercetin-3-O-rutinoside exhibited the highest binding affinity of -8.8 kcal/mol, and most flavonols have interactions with the Cys145 and Glu166 active site residues of SARS-CoV-2 3CLpro crystal structure (6LU7). F. vulgare seed extract is also revealed to successfully inhibit SARS-CoV-2 3CLpro with a half-maximum inhibitory concentration (IC) of 58.55 ± 7.29 ppm. Overall, the findings are able to provide important insights for further research andinnovation of novel anti SARS-CoV-2 drugs.en_US
dc.language.isoenen_US
dc.publisherIndonesia International Institute for Life Sciencesen_US
dc.relation.ispartofseriesPHA 23-011;T202306105-
dc.subject3CL proen_US
dc.subjectAnti SARS-CoV-2en_US
dc.subjectCOVID-19en_US
dc.subjectFennel Seedsen_US
dc.subjectFlavonolsen_US
dc.titleInvestigation on the potential inhibitory activity of Foeniculum vulgare Seed Extract towards recombinant SARS-CoV-2 3CLproen_US
dc.typeThesisen_US
Appears in Collections:Pharmacy

Files in This Item:
File Description SizeFormat 
Abstract.pdfAbstract69.39 kBAdobe PDFView/Open
Chapter 1.pdfChapter 1112.28 kBAdobe PDFView/Open
Cover.pdfCover90.25 kBAdobe PDFView/Open
PHA 23-011_Cecilia Ashley Chung.pdf
  Restricted Access
Full Text20.53 MBAdobe PDFView/Open Request a copy
References.pdfReferences289.2 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.